Arif Bilal's Form 4 filing
Sarepta Therapeutics, Inc. (SRPT) · filed Jun 25, 2024
- Accession no.
- 0000950170-24-077518
- Filed
- Jun 25, 2024
- Trade date
- Jun 21-25, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.92M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Arif BilalCIK 0001959750 | Officer (Chief Tech Ops Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | Common Stock | MOption exerciseAcquired | +6,250 | – | – | 31,472 | Direct | |
| Jun 24, 2024 | Common Stock | FTax withholdingDisposed | −2,352 | $164.64 | −$387,233.28 | 29,120 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −5,580 | $162.31 | −$905,689.8 | 23,540 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −1,055 | $163.83 | −$172,840.65 | 22,485 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −300 | $164.61 | −$49,383 | 22,185 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −700 | $166.10 | −$116,270 | 21,485 | Direct | |
| Jun 24, 2024 | Common Stock | SSaleDisposed | −224 | $167.13 | −$37,437.12 | 21,261 | Direct | |
| Jun 25, 2024 | Common Stock | SSaleDisposed | −3,898 | $163.23 | −$636,270.54 | 17,363 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | Common Stock | AGrant or awardAcquired | +6,250 | $0.00 | $0 | 6,250 | Direct | |
| Jun 21, 2024 | Common Stock | MOption exerciseDisposed | −6,250 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.